Director of Corporate FP&A, Cellares
$170-240k
+ Stock options
Cell therapy manufacturing services provider
Be an early applicant
Cell therapy manufacturing services provider
201-500 employees
Be an early applicant
$170-240k
+ Stock options
201-500 employees
Company mission
To accelrete access to life-saving cell therapies.
Role
Who you are
- The ideal candidate thrives in a collaborative, hands-on environment, brings a strong analytical mindset, and can translate complex data into clear, actionable recommendations for leadership
- Bachelor’s degree in finance, accounting, or a related field
- 10+ years of relevant demonstrated financial and leadership experience, preferably in biotech, pharma, life sciences, or manufacturing
- Extensive experience with SAP or other relevant ERP solutions
- Experience with analysis tools and databases such as Power Query, Python, SQL, Power BI, Snowflake, and Tableau
- Highly organized with a meticulous attention to detail and the willingness to be in a hands-on position
- Deep understanding of industry financials
- Proven track record of financial leadership in a fast-paced, dynamic environment
- Strong analytical and problem-solving skills, with the ability to synthesize complex information into clear recommendations
- Excellent communication and interpersonal skills, with the ability to work effectively with both internal teams and external partners
What the job involves
- We’re seeking a highly motivated and detail-oriented Director, Corporate FP&A, to help drive the company’s operational and financial performance in a fast-paced, scaling biotech environment
- This role will lead core FP&A processes, including annual planning, forecasting, and monthly performance reviews, and serve as a trusted partner to functional leaders across Manufacturing, R&D, Commercial, and G&A
- The Director will deliver actionable insights to support decision-making in a capital-intensive, project-driven business
- Lead corporate financial planning processes, including annual operating plan, quarterly forecasts, and monthly budget-to-actual analysis
- Partner with department leaders to align headcount, operating expenses, and capital investments with company milestones
- Build and maintain financial models for cash flow forecasting, scenario planning, and long-range planning
- Provide analysis to evaluate manufacturing cost structures, R&D investment priorities, and commercial launch economics
- Prepare monthly and quarterly management reports with performance commentary for leadership
- Collaborate with Accounting to ensure accurate month-end close and reporting
- Support the preparation of Board and investor materials, including financial updates and KPI's
- Identify opportunities to improve forecasting accuracy, process efficiency, and data integrity
Our take
There is a significant need for efficient, scalable manufacturing of cell therapies in the biopharmaceutical industry. As demand for advanced treatments like CAR T-cell therapies rises, traditional manufacturing methods often struggle with scalability, high costs, and process failures, limiting patients' access to these lifesaving therapies.
In response, Cellares has developed the CEll Shuttle platform, an automated system designed for high-throughput cell therapy production. The Cell Shuttle can manufacture 16 batches simultaneously, cutting batch costs by up to 50%. By integrating advanced technologies for flow cytometry and cell sorting, Cellares enhances operational efficiency, providing comprehensive solutions that accelerate access to therapies.
Partnering with industry leaders like Kite, Bristol Myers Squibb, and Cabeletta Bio further strengthens its market position, showcasing the platform's potential impact. Along with over $355M in funding and a commercial-scale facility in New Jersey, Cellares is well-prepared to scale operations and meet global demand, positioning itself for future growth in the evolving cell therapy landscape.
Steph
Company Specialist at Welcome to the Jungle
Insights
44% employee growth in 12 months
Company
Funding (last 2 of 3 rounds)
Aug 2023
$255m
SERIES C
May 2021
$82m
SERIES B
Total funding: $355m
Company benefits
- Holidays & Flexible Vacation
- Parental Leave
- Comprehensive Healthcare
- 401k + Company Match
- Catered Onsite Meals
- Premium Technology
- EV Charging
- Professional Development
Company HQ
The East Side, South San Francisco, CA
Leadership
Fabian Gerlinghaus
(Co-Founder & CEO)Graduated from the University of Munich with a Master's Degree in Aerospace Engineering. Prior to co-founding Cellares in 2019, they were the CHief Innovation officer at Synthego.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 3 more jobs at Cellares